Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,781,871
-$6,457,254 QoQ
Shares Held
876,841
-4.1% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $3,507,440,445 across 76 Drug Manufacturers - Specialty & Generic names. SUPN ranks #19 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,878,849 | $638,034,078 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
7,152,498 | $247,977,102 | |
| 3 | VTRS |
Viatris Inc
|
15,128,899 | $240,246,911 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
436,699 | $236,616,614 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,968,719 | $236,100,195 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,318,607 | $222,238,016 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
7,854,362 | $193,295,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,726,303 | $191,516,050 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,781,871 | 876,841 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $47,239,125 | 913,893 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $53,649,706 | 1,079,471 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $36,096,596 | 755,317 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $21,867,060 | 693,752 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $21,282,191 | 649,838 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,504,435 | 677,667 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $22,640,199 | 726,113 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $17,937,665 | 670,567 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,179,206 | 650,226 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $20,933,889 | 723,355 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $14,572,920 | 528,579 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $16,710,290 | 555,898 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,596,260 | 540,885 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,054,897 | 730,443 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,457,593 | 515,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,708,914 | 474,029 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,520,991 | 232,704 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $8,107,993 | 278,052 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,994,265 | 224,757 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,101,739 | 263,129 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $5,096,486 | 194,671 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,750,593 | 228,561 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,420,130 | 404,037 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $14,720,866 | 619,826 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $20,546,538 | 1,142,109 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||